Episode
Supreme Court Keeps Abortion Pill Access Wide Open
- Published
- May 15, 2026
- Duration seconds
- 107
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/austin-news-today-2-min-news-the-daily-news-now-7463304/episodes/supreme-court-keeps-abortion-pill-access-wide-open-2/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/austin-news-today-2-min-news-the-daily-news-now-7463304/supreme-court-keeps-abortion-pill-access-wide-open-2.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Supreme Court Preserves Access to Abortion Pill, Blocking In-Person Visits and Mail Restrictions The Supreme Court has maintained access to mifepristone, the abortion pill used in most medication abortions, by rejecting lower court attempts to enforce in-person doctor visits and prohibit mail or pharmacy pickups. This decision allows women to easily obtain the pill while the major lawsuit continues, likely uninterrupted until at least next year. The controversy began when Louisiana sued the FDA over rules relaxed five years ago, after the drug was approved for abortions in 2000. Anti-abortion groups argue that the pill circumvents state bans by mailing it in, citing an old 1900s law against it. Lower courts partially agreed with them, but the Supreme Court intervened on an emergency appeal from the drug makers. Both sides are passionate about the issue. Abortion rights groups are relieved, stating that patients should not have to wait on judges for basic healthcare. Anti-abortion advocates are disappointed but hopeful that the full case could still result in restrictions. Justices Thomas and Alito dissented, criticizing the companies for profiting from what they view as illegal distribution. Medication abortions, like the one with mifepristone and misoprostol, accounted for nearly two-thirds of all U.S. abortions in 2023. This decision echoes past fights when the court kept access stable and doctors without standing were dismissed. The FDA has supported the pills safety for over 25 years despite ongoing challenges. For now, the status quo remains as appeals progress, keeping this crucial option available amid post-Roe battles. However, everyone is closely watching for the next ruling that could change the game. Support the show: Get a discount at https://solipillow.com…